We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-4.7%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$310M
AUM Growth
-$45M
Cap. Flow
+$408K
Cap. Flow %
0.13%
Top 10 Hldgs %
99.09%
Holding
13
New
2
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
MGNX icon
MacroGenics
MGNX
+$46.6M
2
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$259K

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$38.1M
2
ZLCS
ZALICUS INC COM NEW
ZLCS
+$6.68M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.68M

Sector Composition

Rank Sector Weight
1 Healthcare 96.24%
2 Miscellaneous 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PETX
1
DELISTED
Aratana Therapeutics, Inc.
PETX
$83.1M 26.84%
4,351,048
– –
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$62.9M 20.3%
2,441,344
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$59.9M 19.35%
2,880,485
– –
MGNX icon
4
MacroGenics
MGNX
$263M
$48.9M 15.78%
+1,780,955
New +$46.6M
ALT icon
5
Altimmune
ALT
$605M
$11.8M 3.81%
21,159
– –
VSTM icon
6
Verastem
VSTM
$654M
$11.8M 3.8%
86,110
– –
KBIO
7
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$11.6M 3.76%
329,116
– –
HSTO
8
DELISTED
Histogen Inc. Common Stock
HSTO
$7.69M 2.48%
5,960
– –
PCRX icon
9
Pacira BioSciences
PCRX
$1.03B
$5.75M 1.86%
100,000
-724,255
-88% -$38.1M
ETRM
10
DELISTED
EnteroMedics Inc.
ETRM
$3.41M 1.1%
1,590
– –
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.51M 0.81%
137,212
-83,684
-38% -$1.68M
SGMO
12
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$312K 0.1%
+22,487
New +$259K
ZLCS
13
DELISTED
ZALICUS INC COM NEW
ZLCS
– –
-927,830
Closed -$6.68M

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, MPM Asset Management held 13 positions worth $310M, down 13% from $355M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

MPM Asset Management's Q4 2013 filing shows 2 new, 2 reduced and 1 closed positions. Its largest new stake was MacroGenics: 1,780,955 shares worth $48.9M. The largest sale was Pacira BioSciences, an estimated $38.1M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Miscellaneous.

  • MPM Asset Management's largest Q4 2013 buy was MacroGenics: 1,780,955 shares worth $48.9M.
  • MPM Asset Management's biggest Q4 2013 reduction was Pacira BioSciences, cutting an estimated $38.1M.
  • MPM Asset Management fully exited ZALICUS INC COM NEW in Q4 2013, selling an estimated $6.68M.
  • MPM Asset Management's ten largest holdings make up 99% of its $310M portfolio in Q4 2013.
  • MPM Asset Management opened 2 new positions and closed 1 in Q4 2013.
  • MPM Asset Management's portfolio value fell 13% quarter-over-quarter to $310M.

Based on MPM Asset Management's 13F filing for Q4 2013, filed 23 Jan 2014.